FF:11216-116B1: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity= | |sample_ethnicity= | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;2.64718468487824e-230!GO:0005737;cytoplasm;1.29883316725519e-201!GO:0043226;organelle;1.20586778319971e-175!GO:0043229;intracellular organelle;4.43987557901535e-175!GO:0043231;intracellular membrane-bound organelle;1.05523760508489e-163!GO:0043227;membrane-bound organelle;1.68255155505149e-163!GO:0044444;cytoplasmic part;1.92001647961008e-134!GO:0044422;organelle part;4.2017668642594e-124!GO:0044446;intracellular organelle part;1.46427634785315e-122!GO:0032991;macromolecular complex;1.15194865452079e-79!GO:0044238;primary metabolic process;2.73914577841554e-78!GO:0044237;cellular metabolic process;3.23958710035513e-75!GO:0005515;protein binding;5.07376029823209e-75!GO:0030529;ribonucleoprotein complex;2.07132572973994e-72!GO:0043170;macromolecule metabolic process;1.46795065729425e-69!GO:0043233;organelle lumen;8.87417324147267e-58!GO:0031974;membrane-enclosed lumen;8.87417324147267e-58!GO:0003723;RNA binding;8.13752812061574e-56!GO:0005739;mitochondrion;6.54575853557851e-55!GO:0019538;protein metabolic process;7.0385608644854e-54!GO:0044428;nuclear part;7.11080964780371e-54!GO:0031090;organelle membrane;1.30076950843582e-53!GO:0005634;nucleus;3.7563554048968e-53!GO:0006412;translation;2.64490426784188e-48!GO:0033036;macromolecule localization;3.28154794307322e-47!GO:0015031;protein transport;4.66868483671221e-47!GO:0044267;cellular protein metabolic process;4.11138399546159e-46!GO:0044260;cellular macromolecule metabolic process;4.81636605070398e-46!GO:0005840;ribosome;2.67425699390814e-45!GO:0045184;establishment of protein localization;1.96461195953336e-44!GO:0008104;protein localization;1.96461195953336e-44!GO:0016043;cellular component organization and biogenesis;1.75668160479815e-42!GO:0009058;biosynthetic process;5.14865110499048e-42!GO:0003735;structural constituent of ribosome;3.44178754227563e-40!GO:0043234;protein complex;2.30241767418723e-39!GO:0006396;RNA processing;8.65480660151837e-39!GO:0009059;macromolecule biosynthetic process;1.01208290172328e-38!GO:0005829;cytosol;2.30738394850649e-38!GO:0044249;cellular biosynthetic process;1.84497047609982e-36!GO:0044429;mitochondrial part;2.01855483951591e-36!GO:0043283;biopolymer metabolic process;3.15381818679775e-35!GO:0046907;intracellular transport;6.82688379342138e-35!GO:0033279;ribosomal subunit;5.44630159687359e-34!GO:0031981;nuclear lumen;9.61912268559934e-34!GO:0010467;gene expression;3.08479732858915e-33!GO:0031967;organelle envelope;3.02169999507606e-32!GO:0031975;envelope;6.81968108047616e-32!GO:0016071;mRNA metabolic process;5.47723606761733e-31!GO:0006886;intracellular protein transport;1.92383486072267e-30!GO:0065003;macromolecular complex assembly;3.01219443028125e-30!GO:0008380;RNA splicing;1.12728190057539e-29!GO:0043228;non-membrane-bound organelle;3.50702192743752e-29!GO:0043232;intracellular non-membrane-bound organelle;3.50702192743752e-29!GO:0006397;mRNA processing;4.99947624156471e-27!GO:0022607;cellular component assembly;1.39880694430426e-26!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;2.27551219248414e-26!GO:0022613;ribonucleoprotein complex biogenesis and assembly;3.56851903678486e-26!GO:0005830;cytosolic ribosome (sensu Eukaryota);7.86590031637447e-26!GO:0012505;endomembrane system;8.04472656662005e-26!GO:0005783;endoplasmic reticulum;2.00324959276802e-24!GO:0006996;organelle organization and biogenesis;6.19293824797142e-24!GO:0005740;mitochondrial envelope;1.165441317356e-23!GO:0051641;cellular localization;2.52394962653117e-23!GO:0051649;establishment of cellular localization;2.79505491933454e-23!GO:0005794;Golgi apparatus;3.81958455990604e-22!GO:0031966;mitochondrial membrane;5.27527973794712e-22!GO:0005681;spliceosome;1.00639881862339e-21!GO:0044445;cytosolic part;2.14599365379342e-21!GO:0019866;organelle inner membrane;2.36411351847662e-20!GO:0005654;nucleoplasm;4.9620691229342e-20!GO:0044432;endoplasmic reticulum part;1.05630172812465e-19!GO:0006457;protein folding;1.87501436007481e-19!GO:0006119;oxidative phosphorylation;2.89319262062936e-19!GO:0005743;mitochondrial inner membrane;5.34777041121832e-19!GO:0016874;ligase activity;1.01536486351524e-18!GO:0048770;pigment granule;1.47409195298511e-18!GO:0042470;melanosome;1.47409195298511e-18!GO:0016462;pyrophosphatase activity;1.59783547665953e-18!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;1.8273254996796e-18!GO:0016817;hydrolase activity, acting on acid anhydrides;2.31463687888474e-18!GO:0000166;nucleotide binding;8.25537705157787e-18!GO:0017111;nucleoside-triphosphatase activity;8.71048723458376e-18!GO:0015934;large ribosomal subunit;1.28417147325818e-17!GO:0015935;small ribosomal subunit;2.83836877781024e-17!GO:0022618;protein-RNA complex assembly;3.0661854465315e-17!GO:0051603;proteolysis involved in cellular protein catabolic process;3.32623193645014e-17!GO:0043285;biopolymer catabolic process;5.22646457638165e-17!GO:0019941;modification-dependent protein catabolic process;6.8596882838772e-17!GO:0043632;modification-dependent macromolecule catabolic process;6.8596882838772e-17!GO:0044257;cellular protein catabolic process;1.01360807265907e-16!GO:0006511;ubiquitin-dependent protein catabolic process;1.32942598639762e-16!GO:0044265;cellular macromolecule catabolic process;1.77054380171121e-16!GO:0006512;ubiquitin cycle;2.76401444100692e-16!GO:0044451;nucleoplasm part;2.8800747080448e-16!GO:0044455;mitochondrial membrane part;6.82055005372105e-16!GO:0030163;protein catabolic process;8.91110033703553e-16!GO:0048193;Golgi vesicle transport;1.60851203735356e-15!GO:0016192;vesicle-mediated transport;1.62355124624745e-15!GO:0009057;macromolecule catabolic process;1.73250735647931e-15!GO:0031980;mitochondrial lumen;2.17549625418812e-15!GO:0005759;mitochondrial matrix;2.17549625418812e-15!GO:0006605;protein targeting;2.78951627018473e-15!GO:0042175;nuclear envelope-endoplasmic reticulum network;4.33088113283881e-15!GO:0012501;programmed cell death;4.54178460986588e-15!GO:0005730;nucleolus;4.90855690025057e-15!GO:0005789;endoplasmic reticulum membrane;8.03876564533618e-15!GO:0006915;apoptosis;9.88947678706487e-15!GO:0008134;transcription factor binding;1.33630516149178e-14!GO:0043412;biopolymer modification;1.35761793130925e-14!GO:0000502;proteasome complex (sensu Eukaryota);1.62187580070918e-14!GO:0044248;cellular catabolic process;1.95026171941815e-14!GO:0051082;unfolded protein binding;2.45470755335028e-14!GO:0006259;DNA metabolic process;2.83806982518226e-14!GO:0051186;cofactor metabolic process;1.44768220441474e-13!GO:0008135;translation factor activity, nucleic acid binding;1.56802895398586e-13!GO:0032553;ribonucleotide binding;1.64610440077468e-13!GO:0032555;purine ribonucleotide binding;1.64610440077468e-13!GO:0006464;protein modification process;1.77744644586879e-13!GO:0005746;mitochondrial respiratory chain;2.17534702303445e-13!GO:0008219;cell death;2.37431617634045e-13!GO:0016265;death;2.37431617634045e-13!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.20260379081906e-13!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3.85487735829453e-13!GO:0017076;purine nucleotide binding;3.99694580915047e-13!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);4.20747032003669e-13!GO:0016070;RNA metabolic process;8.31835025161038e-13!GO:0006461;protein complex assembly;1.86355144048499e-12!GO:0003676;nucleic acid binding;3.96875558084747e-12!GO:0005761;mitochondrial ribosome;4.58014375033897e-12!GO:0000313;organellar ribosome;4.58014375033897e-12!GO:0050136;NADH dehydrogenase (quinone) activity;4.73386869121081e-12!GO:0003954;NADH dehydrogenase activity;4.73386869121081e-12!GO:0008137;NADH dehydrogenase (ubiquinone) activity;4.73386869121081e-12!GO:0007049;cell cycle;7.09830307592474e-12!GO:0006732;coenzyme metabolic process;1.47123394490074e-11!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;3.49802644746285e-11!GO:0000398;nuclear mRNA splicing, via spliceosome;4.35969449922715e-11!GO:0000375;RNA splicing, via transesterification reactions;4.35969449922715e-11!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;4.35969449922715e-11!GO:0043687;post-translational protein modification;4.54103261431973e-11!GO:0006413;translational initiation;6.72042620811845e-11!GO:0044431;Golgi apparatus part;6.72042620811845e-11!GO:0043067;regulation of programmed cell death;6.76734747117531e-11!GO:0042981;regulation of apoptosis;8.54517026104126e-11!GO:0008565;protein transporter activity;1.07467875477513e-10!GO:0042775;organelle ATP synthesis coupled electron transport;1.54124462243734e-10!GO:0042773;ATP synthesis coupled electron transport;1.54124462243734e-10!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;1.57460382386892e-10!GO:0003743;translation initiation factor activity;1.68684045434147e-10!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.74289579873604e-10!GO:0005768;endosome;1.92377063345746e-10!GO:0006446;regulation of translational initiation;2.18857596795114e-10!GO:0005793;ER-Golgi intermediate compartment;2.31283962255601e-10!GO:0030964;NADH dehydrogenase complex (quinone);2.46378943005976e-10!GO:0045271;respiratory chain complex I;2.46378943005976e-10!GO:0005747;mitochondrial respiratory chain complex I;2.46378943005976e-10!GO:0042254;ribosome biogenesis and assembly;2.48452160723579e-10!GO:0008639;small protein conjugating enzyme activity;3.36970716730414e-10!GO:0016879;ligase activity, forming carbon-nitrogen bonds;4.56527743629242e-10!GO:0007249;I-kappaB kinase/NF-kappaB cascade;4.87576187600409e-10!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;5.9547988146562e-10!GO:0004842;ubiquitin-protein ligase activity;6.24417898036971e-10!GO:0019787;small conjugating protein ligase activity;6.71298636870084e-10!GO:0048523;negative regulation of cellular process;6.86479522749488e-10!GO:0051246;regulation of protein metabolic process;9.48692262223354e-10!GO:0003924;GTPase activity;9.48692262223354e-10!GO:0048475;coated membrane;1.20740698834969e-09!GO:0030117;membrane coat;1.20740698834969e-09!GO:0005524;ATP binding;1.36748699521151e-09!GO:0009056;catabolic process;1.38015497806045e-09!GO:0005635;nuclear envelope;2.04301944024889e-09!GO:0032559;adenyl ribonucleotide binding;2.51138065879077e-09!GO:0050794;regulation of cellular process;2.5780683997344e-09!GO:0006913;nucleocytoplasmic transport;3.01358749884205e-09!GO:0016604;nuclear body;3.02922484413988e-09!GO:0009259;ribonucleotide metabolic process;3.73774842707048e-09!GO:0030120;vesicle coat;4.37356190995636e-09!GO:0030662;coated vesicle membrane;4.37356190995636e-09!GO:0003712;transcription cofactor activity;5.05673979739154e-09!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;6.2921099156841e-09!GO:0030554;adenyl nucleotide binding;6.86088509205188e-09!GO:0051169;nuclear transport;6.86422976078527e-09!GO:0006163;purine nucleotide metabolic process;7.32280162152937e-09!GO:0000139;Golgi membrane;7.62301224511764e-09!GO:0016881;acid-amino acid ligase activity;9.31874453783984e-09!GO:0031965;nuclear membrane;1.18622643930552e-08!GO:0006974;response to DNA damage stimulus;1.29010033269306e-08!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.35766955232586e-08!GO:0048519;negative regulation of biological process;1.6320780626878e-08!GO:0009150;purine ribonucleotide metabolic process;1.71404024314132e-08!GO:0009055;electron carrier activity;3.03106504641433e-08!GO:0006888;ER to Golgi vesicle-mediated transport;3.41810859953954e-08!GO:0006164;purine nucleotide biosynthetic process;3.42862173543761e-08!GO:0009141;nucleoside triphosphate metabolic process;3.77831030448017e-08!GO:0009260;ribonucleotide biosynthetic process;4.65791036299616e-08!GO:0044453;nuclear membrane part;4.79776976297995e-08!GO:0009199;ribonucleoside triphosphate metabolic process;5.25864675889614e-08!GO:0015986;ATP synthesis coupled proton transport;5.43209679881782e-08!GO:0015985;energy coupled proton transport, down electrochemical gradient;5.43209679881782e-08!GO:0031252;leading edge;5.43582514321671e-08!GO:0016607;nuclear speck;6.03078947528212e-08!GO:0009142;nucleoside triphosphate biosynthetic process;7.60688975526205e-08!GO:0009201;ribonucleoside triphosphate biosynthetic process;7.60688975526205e-08!GO:0009152;purine ribonucleotide biosynthetic process;7.7598416904346e-08!GO:0009205;purine ribonucleoside triphosphate metabolic process;9.36772570753267e-08!GO:0009144;purine nucleoside triphosphate metabolic process;9.36772570753267e-08!GO:0031988;membrane-bound vesicle;1.03136893195009e-07!GO:0000074;regulation of progression through cell cycle;1.0831587867095e-07!GO:0022402;cell cycle process;1.11795779488842e-07!GO:0016023;cytoplasmic membrane-bound vesicle;1.12409595491008e-07!GO:0016887;ATPase activity;1.1727549365281e-07!GO:0051726;regulation of cell cycle;1.3024471250335e-07!GO:0006399;tRNA metabolic process;1.30853049795853e-07!GO:0005525;GTP binding;1.32595695401006e-07!GO:0042623;ATPase activity, coupled;1.36205679938505e-07!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;1.36433137759136e-07!GO:0009145;purine nucleoside triphosphate biosynthetic process;1.36433137759136e-07!GO:0043069;negative regulation of programmed cell death;1.48974539561963e-07!GO:0009060;aerobic respiration;1.69128606569764e-07!GO:0051188;cofactor biosynthetic process;1.92645196453574e-07!GO:0017038;protein import;2.19756149318161e-07!GO:0009967;positive regulation of signal transduction;2.3057967144261e-07!GO:0005773;vacuole;2.37272380658056e-07!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;3.25602362028208e-07!GO:0004812;aminoacyl-tRNA ligase activity;3.25602362028208e-07!GO:0016875;ligase activity, forming carbon-oxygen bonds;3.25602362028208e-07!GO:0006366;transcription from RNA polymerase II promoter;3.54088643557263e-07!GO:0043066;negative regulation of apoptosis;4.04922702348278e-07!GO:0030532;small nuclear ribonucleoprotein complex;4.28645636073229e-07!GO:0048522;positive regulation of cellular process;4.34674560935295e-07!GO:0043038;amino acid activation;4.86698587023546e-07!GO:0006418;tRNA aminoacylation for protein translation;4.86698587023546e-07!GO:0043039;tRNA aminoacylation;4.86698587023546e-07!GO:0019829;cation-transporting ATPase activity;4.95735556407472e-07!GO:0031982;vesicle;5.33980548363597e-07!GO:0006281;DNA repair;6.20021612730078e-07!GO:0007005;mitochondrion organization and biogenesis;6.75353122362517e-07!GO:0009719;response to endogenous stimulus;6.83999237106769e-07!GO:0046034;ATP metabolic process;6.8672681513484e-07!GO:0007243;protein kinase cascade;7.87162407266517e-07!GO:0006754;ATP biosynthetic process;8.37941280151674e-07!GO:0006753;nucleoside phosphate metabolic process;8.37941280151674e-07!GO:0031410;cytoplasmic vesicle;8.47275187137115e-07!GO:0006916;anti-apoptosis;9.68559260242125e-07!GO:0045333;cellular respiration;9.75164665776547e-07!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;1.07088740460957e-06!GO:0005770;late endosome;1.18827160563379e-06!GO:0000278;mitotic cell cycle;1.19215793172752e-06!GO:0032446;protein modification by small protein conjugation;1.19215793172752e-06!GO:0004386;helicase activity;1.31855784480861e-06!GO:0044440;endosomal part;1.62229143220384e-06!GO:0010008;endosome membrane;1.62229143220384e-06!GO:0005643;nuclear pore;1.62862296427633e-06!GO:0006752;group transfer coenzyme metabolic process;1.70218206073863e-06!GO:0016740;transferase activity;1.85350798101643e-06!GO:0016072;rRNA metabolic process;1.93278540643414e-06!GO:0006099;tricarboxylic acid cycle;1.93278540643414e-06!GO:0046356;acetyl-CoA catabolic process;1.93278540643414e-06!GO:0016567;protein ubiquitination;2.04604290670674e-06!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;2.194233349484e-06!GO:0009109;coenzyme catabolic process;2.22961224568305e-06!GO:0051187;cofactor catabolic process;2.31169066137034e-06!GO:0000323;lytic vacuole;2.37110193104191e-06!GO:0005764;lysosome;2.37110193104191e-06!GO:0009108;coenzyme biosynthetic process;2.5643097217292e-06!GO:0006364;rRNA processing;2.57488222333535e-06!GO:0065002;intracellular protein transport across a membrane;2.60627107788309e-06!GO:0005798;Golgi-associated vesicle;2.78228343497467e-06!GO:0032561;guanyl ribonucleotide binding;3.04213378460893e-06!GO:0019001;guanyl nucleotide binding;3.04213378460893e-06!GO:0005839;proteasome core complex (sensu Eukaryota);3.08379517250115e-06!GO:0016469;proton-transporting two-sector ATPase complex;3.53611860909332e-06!GO:0015078;hydrogen ion transmembrane transporter activity;3.96412008557163e-06!GO:0050789;regulation of biological process;3.98001287673422e-06!GO:0005788;endoplasmic reticulum lumen;5.26738817079695e-06!GO:0009117;nucleotide metabolic process;6.53139046753681e-06!GO:0006084;acetyl-CoA metabolic process;6.53139046753681e-06!GO:0006613;cotranslational protein targeting to membrane;7.67633545701781e-06!GO:0000245;spliceosome assembly;8.29448745213853e-06!GO:0001726;ruffle;8.38288043148052e-06!GO:0030036;actin cytoskeleton organization and biogenesis;8.82558037033744e-06!GO:0006325;establishment and/or maintenance of chromatin architecture;9.29514770733529e-06!GO:0016787;hydrolase activity;9.37836326930812e-06!GO:0042802;identical protein binding;1.02918875304825e-05!GO:0008026;ATP-dependent helicase activity;1.08912376858005e-05!GO:0045259;proton-transporting ATP synthase complex;1.15363372315237e-05!GO:0051170;nuclear import;1.15610379229597e-05!GO:0050657;nucleic acid transport;1.15610379229597e-05!GO:0051236;establishment of RNA localization;1.15610379229597e-05!GO:0050658;RNA transport;1.15610379229597e-05!GO:0006403;RNA localization;1.34202844283197e-05!GO:0043623;cellular protein complex assembly;1.41537157519682e-05!GO:0065009;regulation of a molecular function;1.41850680919239e-05!GO:0007264;small GTPase mediated signal transduction;1.69351026697371e-05!GO:0008092;cytoskeletal protein binding;1.7045588783459e-05!GO:0006793;phosphorus metabolic process;1.71693832383006e-05!GO:0006796;phosphate metabolic process;1.71693832383006e-05!GO:0004298;threonine endopeptidase activity;1.90464490641748e-05!GO:0008654;phospholipid biosynthetic process;2.00212706828443e-05!GO:0019899;enzyme binding;2.02373560229961e-05!GO:0006323;DNA packaging;2.38183632757849e-05!GO:0006606;protein import into nucleus;2.46581109799388e-05!GO:0030118;clathrin coat;2.77950958643679e-05!GO:0031202;RNA splicing factor activity, transesterification mechanism;3.21655467899153e-05!GO:0046930;pore complex;3.4677567956921e-05!GO:0048518;positive regulation of biological process;4.01334781760224e-05!GO:0051276;chromosome organization and biogenesis;4.39496043909055e-05!GO:0016563;transcription activator activity;4.60058353728509e-05!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;4.77839383617127e-05!GO:0016859;cis-trans isomerase activity;5.07218388453461e-05!GO:0031324;negative regulation of cellular metabolic process;5.79649178438394e-05!GO:0016491;oxidoreductase activity;6.05658553085909e-05!GO:0030029;actin filament-based process;6.52575864946191e-05!GO:0006612;protein targeting to membrane;8.26006184462088e-05!GO:0005769;early endosome;8.41359696766822e-05!GO:0016779;nucleotidyltransferase activity;8.41359696766822e-05!GO:0003713;transcription coactivator activity;8.9330916292176e-05!GO:0016310;phosphorylation;9.21558573680112e-05!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.000111531495757572!GO:0016853;isomerase activity;0.000113146273983881!GO:0030867;rough endoplasmic reticulum membrane;0.000118848406900951!GO:0045786;negative regulation of progression through cell cycle;0.000124916916589642!GO:0016126;sterol biosynthetic process;0.000125618413623974!GO:0003714;transcription corepressor activity;0.000130719306451131!GO:0005762;mitochondrial large ribosomal subunit;0.000141673914283532!GO:0000315;organellar large ribosomal subunit;0.000141673914283532!GO:0030119;AP-type membrane coat adaptor complex;0.000141951178904451!GO:0031968;organelle outer membrane;0.000143734921186239!GO:0043566;structure-specific DNA binding;0.000150005646980857!GO:0043021;ribonucleoprotein binding;0.000151648819964198!GO:0003724;RNA helicase activity;0.000155186064225822!GO:0016568;chromatin modification;0.000171912118318788!GO:0051789;response to protein stimulus;0.000174873381127794!GO:0006986;response to unfolded protein;0.000174873381127794!GO:0006260;DNA replication;0.000180910643192474!GO:0009892;negative regulation of metabolic process;0.000186599115570176!GO:0019867;outer membrane;0.000190919979925524!GO:0033116;ER-Golgi intermediate compartment membrane;0.00020170075817781!GO:0005667;transcription factor complex;0.000222083987633402!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.000226552049521543!GO:0016564;transcription repressor activity;0.000232834255712561!GO:0030131;clathrin adaptor complex;0.000265155603111712!GO:0005905;coated pit;0.000270137555500095!GO:0051427;hormone receptor binding;0.000274812211066293!GO:0045454;cell redox homeostasis;0.000278405879638536!GO:0003697;single-stranded DNA binding;0.000279812406431256!GO:0051301;cell division;0.000288145405972182!GO:0048471;perinuclear region of cytoplasm;0.000289481494257181!GO:0005741;mitochondrial outer membrane;0.000293076221972601!GO:0016044;membrane organization and biogenesis;0.000295776691589975!GO:0030133;transport vesicle;0.000300996656102258!GO:0051028;mRNA transport;0.000310576814299593!GO:0030658;transport vesicle membrane;0.000336437927837006!GO:0008250;oligosaccharyl transferase complex;0.000337841552724835!GO:0004576;oligosaccharyl transferase activity;0.000389719409910722!GO:0007010;cytoskeleton organization and biogenesis;0.000390812149321203!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000414967597590805!GO:0015630;microtubule cytoskeleton;0.000433972315683595!GO:0005694;chromosome;0.000434568205911654!GO:0005885;Arp2/3 protein complex;0.000439832372901928!GO:0035257;nuclear hormone receptor binding;0.000458398017804937!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.000459439482398679!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000459469435440104!GO:0005048;signal sequence binding;0.00050446357768719!GO:0008610;lipid biosynthetic process;0.000514546897151377!GO:0000151;ubiquitin ligase complex;0.000530520245467738!GO:0006417;regulation of translation;0.000535955357577711!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.00063185637836465!GO:0030027;lamellipodium;0.000634960516297513!GO:0030031;cell projection biogenesis;0.000637431980760263!GO:0000087;M phase of mitotic cell cycle;0.000654110462873523!GO:0006891;intra-Golgi vesicle-mediated transport;0.000701862889633011!GO:0065004;protein-DNA complex assembly;0.00070346195793111!GO:0050790;regulation of catalytic activity;0.000752706437915341!GO:0007067;mitosis;0.000765560320960338!GO:0008632;apoptotic program;0.000854575399645244!GO:0051252;regulation of RNA metabolic process;0.000863742409545136!GO:0005813;centrosome;0.000886972204409144!GO:0043065;positive regulation of apoptosis;0.00093445585579955!GO:0045045;secretory pathway;0.000988077459314287!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00100555067523368!GO:0006695;cholesterol biosynthetic process;0.00100580356474419!GO:0016197;endosome transport;0.00100722485870781!GO:0018196;peptidyl-asparagine modification;0.00104638591216105!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00104638591216105!GO:0043068;positive regulation of programmed cell death;0.00108525489321485!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00112427166111863!GO:0019222;regulation of metabolic process;0.00115352559228335!GO:0030663;COPI coated vesicle membrane;0.00117741716361914!GO:0030126;COPI vesicle coat;0.00117741716361914!GO:0051920;peroxiredoxin activity;0.00119439206274373!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.00119650405521359!GO:0030132;clathrin coat of coated pit;0.00119950475622196!GO:0048468;cell development;0.00125209336053352!GO:0030660;Golgi-associated vesicle membrane;0.00125221160251399!GO:0031072;heat shock protein binding;0.00130192269077857!GO:0000314;organellar small ribosomal subunit;0.00131950763791952!GO:0005763;mitochondrial small ribosomal subunit;0.00131950763791952!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.0013432757080574!GO:0000785;chromatin;0.0013739403081434!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00141427569098293!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00141427569098293!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00141427569098293!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00148153312502441!GO:0016481;negative regulation of transcription;0.00153768034476813!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00169635871771434!GO:0006333;chromatin assembly or disassembly;0.00169760036553277!GO:0048500;signal recognition particle;0.00180967960952822!GO:0005791;rough endoplasmic reticulum;0.00189893491582377!GO:0030176;integral to endoplasmic reticulum membrane;0.00212172730322492!GO:0043488;regulation of mRNA stability;0.00212691751253967!GO:0043487;regulation of RNA stability;0.00212691751253967!GO:0065007;biological regulation;0.00212691751253967!GO:0046474;glycerophospholipid biosynthetic process;0.00221082182247606!GO:0022403;cell cycle phase;0.0022140807577609!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.002215832490042!GO:0015399;primary active transmembrane transporter activity;0.002215832490042!GO:0030137;COPI-coated vesicle;0.00228156420901706!GO:0051168;nuclear export;0.00230801076989094!GO:0008186;RNA-dependent ATPase activity;0.00248254102884095!GO:0005815;microtubule organizing center;0.00251274103582936!GO:0030134;ER to Golgi transport vesicle;0.00253802182406561!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00283449074887842!GO:0030127;COPII vesicle coat;0.00283449074887842!GO:0012507;ER to Golgi transport vesicle membrane;0.00283449074887842!GO:0044427;chromosomal part;0.00283449074887842!GO:0030659;cytoplasmic vesicle membrane;0.00298664155979534!GO:0006091;generation of precursor metabolites and energy;0.00299465898864063!GO:0030125;clathrin vesicle coat;0.00306690334540636!GO:0030665;clathrin coated vesicle membrane;0.00306690334540636!GO:0051098;regulation of binding;0.00307445386870804!GO:0019843;rRNA binding;0.00311398148031602!GO:0046489;phosphoinositide biosynthetic process;0.00315082960088815!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.00330550634816811!GO:0032940;secretion by cell;0.0034298254542699!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.00366952796731837!GO:0015980;energy derivation by oxidation of organic compounds;0.00376624359439434!GO:0030833;regulation of actin filament polymerization;0.00382717277172085!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.00398285069827648!GO:0046467;membrane lipid biosynthetic process;0.00400791256913692!GO:0008637;apoptotic mitochondrial changes;0.00404488957109461!GO:0007006;mitochondrial membrane organization and biogenesis;0.0040959964827993!GO:0016363;nuclear matrix;0.00413399062036432!GO:0031326;regulation of cellular biosynthetic process;0.00418630381128614!GO:0031902;late endosome membrane;0.00419351949718536!GO:0008139;nuclear localization sequence binding;0.00422833112188457!GO:0008361;regulation of cell size;0.00435642412844996!GO:0007242;intracellular signaling cascade;0.00439485677306935!GO:0051128;regulation of cellular component organization and biogenesis;0.00457528778770257!GO:0006626;protein targeting to mitochondrion;0.00463963051736437!GO:0009889;regulation of biosynthetic process;0.00466952060243491!GO:0016125;sterol metabolic process;0.00472421018448331!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00476238937139332!GO:0045047;protein targeting to ER;0.00476238937139332!GO:0006839;mitochondrial transport;0.00488933314078746!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0050127330740113!GO:0005774;vacuolar membrane;0.00509700546660071!GO:0009165;nucleotide biosynthetic process;0.00545974248391688!GO:0006650;glycerophospholipid metabolic process;0.00547150400682866!GO:0006402;mRNA catabolic process;0.00555847563007846!GO:0015631;tubulin binding;0.00556655891801738!GO:0005684;U2-dependent spliceosome;0.00558901670458595!GO:0006383;transcription from RNA polymerase III promoter;0.00583811720849191!GO:0006979;response to oxidative stress;0.00603879267032472!GO:0003729;mRNA binding;0.00617061855176111!GO:0004004;ATP-dependent RNA helicase activity;0.00620327832021461!GO:0009966;regulation of signal transduction;0.00639568018850881!GO:0048487;beta-tubulin binding;0.00640731860806976!GO:0008047;enzyme activator activity;0.00644260943331274!GO:0016049;cell growth;0.00644260943331274!GO:0008312;7S RNA binding;0.0064862982555702!GO:0051329;interphase of mitotic cell cycle;0.00668859433594879!GO:0051101;regulation of DNA binding;0.00670087292366151!GO:0045893;positive regulation of transcription, DNA-dependent;0.00671578948162538!GO:0005856;cytoskeleton;0.00683608018822024!GO:0006509;membrane protein ectodomain proteolysis;0.00695588881121679!GO:0033619;membrane protein proteolysis;0.00695588881121679!GO:0043681;protein import into mitochondrion;0.00699194728054452!GO:0055092;sterol homeostasis;0.00716814477821874!GO:0042632;cholesterol homeostasis;0.00716814477821874!GO:0008234;cysteine-type peptidase activity;0.00727178283954559!GO:0003899;DNA-directed RNA polymerase activity;0.00732958098372718!GO:0051287;NAD binding;0.00743457544803321!GO:0001558;regulation of cell growth;0.00750198261315966!GO:0044433;cytoplasmic vesicle part;0.00753979055516534!GO:0030521;androgen receptor signaling pathway;0.00757564733428691!GO:0006414;translational elongation;0.00757564733428691!GO:0030880;RNA polymerase complex;0.00761455818809227!GO:0016281;eukaryotic translation initiation factor 4F complex;0.00799964372273132!GO:0000049;tRNA binding;0.00821716254188369!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00831319080490657!GO:0046822;regulation of nucleocytoplasmic transport;0.00836275002281318!GO:0007265;Ras protein signal transduction;0.00846248915088578!GO:0017166;vinculin binding;0.00855495282776478!GO:0048144;fibroblast proliferation;0.00895265176667649!GO:0048145;regulation of fibroblast proliferation;0.00895265176667649!GO:0006401;RNA catabolic process;0.0090548358448978!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.00921092718567052!GO:0015992;proton transport;0.00921092718567052!GO:0030041;actin filament polymerization;0.00939471723554295!GO:0046483;heterocycle metabolic process;0.00977280328180753!GO:0006818;hydrogen transport;0.009899751433467!GO:0006595;polyamine metabolic process;0.0103316671538649!GO:0004674;protein serine/threonine kinase activity;0.0105860439964591!GO:0055088;lipid homeostasis;0.0106224886418175!GO:0051336;regulation of hydrolase activity;0.0107912556106854!GO:0003690;double-stranded DNA binding;0.0107921475130753!GO:0048146;positive regulation of fibroblast proliferation;0.0109303996575701!GO:0005869;dynactin complex;0.0109303996575701!GO:0006892;post-Golgi vesicle-mediated transport;0.0109436962313175!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0115375008844582!GO:0031625;ubiquitin protein ligase binding;0.0117803043246147!GO:0030032;lamellipodium biogenesis;0.0118283518476992!GO:0043161;proteasomal ubiquitin-dependent protein catabolic process;0.0118707935933973!GO:0030384;phosphoinositide metabolic process;0.0118935571095977!GO:0051338;regulation of transferase activity;0.0119299443755225!GO:0003711;transcription elongation regulator activity;0.0120173618375165!GO:0051087;chaperone binding;0.0120357749317838!GO:0012506;vesicle membrane;0.0121634956497548!GO:0043492;ATPase activity, coupled to movement of substances;0.0121883307491943!GO:0022890;inorganic cation transmembrane transporter activity;0.0123064114422175!GO:0044255;cellular lipid metabolic process;0.0124386253221929!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0125042985816105!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0125042985816105!GO:0044437;vacuolar part;0.0126057584353291!GO:0000059;protein import into nucleus, docking;0.0127032512989367!GO:0035258;steroid hormone receptor binding;0.0129796837661465!GO:0005149;interleukin-1 receptor binding;0.0129844040485337!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;0.0130805843815045!GO:0043022;ribosome binding;0.0131054259853727!GO:0006917;induction of apoptosis;0.0132915399452458!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.0134375557366707!GO:0008283;cell proliferation;0.0134691518860189!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.0139998516410613!GO:0000428;DNA-directed RNA polymerase complex;0.0139998516410613!GO:0045941;positive regulation of transcription;0.0143772583302551!GO:0050662;coenzyme binding;0.0143772583302551!GO:0008154;actin polymerization and/or depolymerization;0.0143772583302551!GO:0051325;interphase;0.015006309637408!GO:0031529;ruffle organization and biogenesis;0.015456585060585!GO:0005765;lysosomal membrane;0.0156505273070904!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.0159553890931196!GO:0007050;cell cycle arrest;0.0159553890931196!GO:0001836;release of cytochrome c from mitochondria;0.0161877506715833!GO:0006352;transcription initiation;0.0161877506715833!GO:0019752;carboxylic acid metabolic process;0.0162017832227128!GO:0016272;prefoldin complex;0.0167430768027838!GO:0022406;membrane docking;0.0167847912412428!GO:0048278;vesicle docking;0.0167847912412428!GO:0035035;histone acetyltransferase binding;0.0168759378007702!GO:0006082;organic acid metabolic process;0.0169115969820551!GO:0000209;protein polyubiquitination;0.0172336587084838!GO:0012502;induction of programmed cell death;0.0173222678852153!GO:0006950;response to stress;0.0179318990529408!GO:0045792;negative regulation of cell size;0.0180172531600342!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0182647259410662!GO:0005832;chaperonin-containing T-complex;0.0182874034587784!GO:0030145;manganese ion binding;0.0183888943435226!GO:0019904;protein domain specific binding;0.0184044900883656!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0184357373484604!GO:0007034;vacuolar transport;0.0184990347018871!GO:0007266;Rho protein signal transduction;0.0185635774783954!GO:0008180;signalosome;0.0188995966368027!GO:0006611;protein export from nucleus;0.0196176185467076!GO:0032984;macromolecular complex disassembly;0.020259079912221!GO:0003779;actin binding;0.0212556202435893!GO:0009112;nucleobase metabolic process;0.0212556202435893!GO:0033673;negative regulation of kinase activity;0.0212556202435893!GO:0006469;negative regulation of protein kinase activity;0.0212556202435893!GO:0051052;regulation of DNA metabolic process;0.0219860407472114!GO:0008064;regulation of actin polymerization and/or depolymerization;0.022022663075363!GO:0003746;translation elongation factor activity;0.0221513746452261!GO:0030308;negative regulation of cell growth;0.022992583941021!GO:0006643;membrane lipid metabolic process;0.0231190297831459!GO:0043549;regulation of kinase activity;0.0234800680724914!GO:0045892;negative regulation of transcription, DNA-dependent;0.0236821181657425!GO:0016408;C-acyltransferase activity;0.0239727180234425!GO:0006289;nucleotide-excision repair;0.0241013319545597!GO:0016251;general RNA polymerase II transcription factor activity;0.0252798993215726!GO:0043281;regulation of caspase activity;0.0252821582392829!GO:0001666;response to hypoxia;0.0253686064258215!GO:0006354;RNA elongation;0.0253976836283195!GO:0008243;plasminogen activator activity;0.0255838696615918!GO:0006904;vesicle docking during exocytosis;0.0256039717297436!GO:0005819;spindle;0.0260174768362713!GO:0004680;casein kinase activity;0.0261437004475064!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.0261437004475064!GO:0033043;regulation of organelle organization and biogenesis;0.0261437004475064!GO:0006897;endocytosis;0.0261437004475064!GO:0010324;membrane invagination;0.0261437004475064!GO:0006376;mRNA splice site selection;0.0270504566988973!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0270504566988973!GO:0008033;tRNA processing;0.0271091968187651!GO:0008601;protein phosphatase type 2A regulator activity;0.0272840740016677!GO:0008022;protein C-terminus binding;0.0272971584003176!GO:0045926;negative regulation of growth;0.0286802965294223!GO:0006458;'de novo' protein folding;0.029037708471929!GO:0051084;'de novo' posttranslational protein folding;0.029037708471929!GO:0000082;G1/S transition of mitotic cell cycle;0.0292729435009467!GO:0016706;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;0.0294283529639182!GO:0050681;androgen receptor binding;0.0302515860212677!GO:0044452;nucleolar part;0.0303492532465285!GO:0051348;negative regulation of transferase activity;0.0305719373826433!GO:0030433;ER-associated protein catabolic process;0.0310861825008766!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0310861825008766!GO:0045334;clathrin-coated endocytic vesicle;0.0310861825008766!GO:0043256;laminin complex;0.0311136283520882!GO:0006497;protein amino acid lipidation;0.0311136283520882!GO:0005637;nuclear inner membrane;0.0317299070335509!GO:0000279;M phase;0.0323856267133651!GO:0051881;regulation of mitochondrial membrane potential;0.032391272987844!GO:0005938;cell cortex;0.032492092485346!GO:0040008;regulation of growth;0.0326741031533877!GO:0000287;magnesium ion binding;0.0328589720537621!GO:0019205;nucleobase, nucleoside, nucleotide kinase activity;0.0330574092216227!GO:0022408;negative regulation of cell-cell adhesion;0.0331448610830425!GO:0006984;ER-nuclear signaling pathway;0.0334260570991307!GO:0032507;maintenance of cellular protein localization;0.0346511215802493!GO:0030100;regulation of endocytosis;0.0349496195642384!GO:0043624;cellular protein complex disassembly;0.0354308921402427!GO:0043241;protein complex disassembly;0.0354308921402427!GO:0031901;early endosome membrane;0.0356942191102015!GO:0003756;protein disulfide isomerase activity;0.0367275110539574!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0367275110539574!GO:0042158;lipoprotein biosynthetic process;0.0375481518104595!GO:0046519;sphingoid metabolic process;0.0382136591908426!GO:0006644;phospholipid metabolic process;0.0382909880336051!GO:0006506;GPI anchor biosynthetic process;0.0383187602922945!GO:0005801;cis-Golgi network;0.0385396737463912!GO:0051540;metal cluster binding;0.0387953302568485!GO:0051536;iron-sulfur cluster binding;0.0387953302568485!GO:0031272;regulation of pseudopodium formation;0.0390075542377378!GO:0031269;pseudopodium formation;0.0390075542377378!GO:0031344;regulation of cell projection organization and biogenesis;0.0390075542377378!GO:0031268;pseudopodium organization and biogenesis;0.0390075542377378!GO:0031346;positive regulation of cell projection organization and biogenesis;0.0390075542377378!GO:0031274;positive regulation of pseudopodium formation;0.0390075542377378!GO:0009116;nucleoside metabolic process;0.039037223771436!GO:0008203;cholesterol metabolic process;0.0390548133022462!GO:0008426;protein kinase C inhibitor activity;0.0390904638376353!GO:0008629;induction of apoptosis by intracellular signals;0.0390943165147651!GO:0000339;RNA cap binding;0.0397515853083619!GO:0008538;proteasome activator activity;0.0400497045045024!GO:0031371;ubiquitin conjugating enzyme complex;0.0400497045045024!GO:0008097;5S rRNA binding;0.0400675317408941!GO:0043154;negative regulation of caspase activity;0.04010768137717!GO:0006144;purine base metabolic process;0.0401543782192867!GO:0006334;nucleosome assembly;0.0412731550749635!GO:0000288;mRNA catabolic process, deadenylation-dependent decay;0.0418836390488322!GO:0031323;regulation of cellular metabolic process;0.0419241474654314!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0434034351860114!GO:0015002;heme-copper terminal oxidase activity;0.0434034351860114!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0434034351860114!GO:0004129;cytochrome-c oxidase activity;0.0434034351860114!GO:0030139;endocytic vesicle;0.0442020487325961!GO:0048660;regulation of smooth muscle cell proliferation;0.0445130074853433!GO:0005784;translocon complex;0.0450415864618013!GO:0007040;lysosome organization and biogenesis;0.0451823254036295!GO:0031301;integral to organelle membrane;0.0453761376713483!GO:0006505;GPI anchor metabolic process;0.0456119746964954!GO:0007030;Golgi organization and biogenesis;0.0469842631383063!GO:0046983;protein dimerization activity;0.0475272380672028!GO:0030911;TPR domain binding;0.0482883912780345!GO:0030140;trans-Golgi network transport vesicle;0.0486727504060761!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;0.0486727504060761!GO:0045859;regulation of protein kinase activity;0.0488956571934042!GO:0007032;endosome organization and biogenesis;0.0491989521268953!GO:0044262;cellular carbohydrate metabolic process;0.0491989521268953!GO:0016584;nucleosome positioning;0.0491989521268953!GO:0030838;positive regulation of actin filament polymerization;0.0491989521268953!GO:0016791;phosphoric monoester hydrolase activity;0.0491989521268953!GO:0004197;cysteine-type endopeptidase activity;0.0496211450764765!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0496324917895845 | |||
|sample_id=11216 | |sample_id=11216 | ||
|sample_note=machine failed, remainder reloaded, low amount | |sample_note=machine failed, remainder reloaded, low amount |
Revision as of 21:40, 25 June 2012
Name: | Urothelial cells, donor0 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10843
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10843
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.859 |
10 | 10 | 0.382 |
100 | 100 | 0.563 |
101 | 101 | 0.481 |
102 | 102 | 0.382 |
103 | 103 | 0.0634 |
104 | 104 | 0.721 |
105 | 105 | 0.46 |
106 | 106 | 0.0323 |
107 | 107 | 0.00757 |
108 | 108 | 0.176 |
109 | 109 | 0.0662 |
11 | 11 | 0.471 |
110 | 110 | 0.464 |
111 | 111 | 0.0255 |
112 | 112 | 0.592 |
113 | 113 | 0.0146 |
114 | 114 | 0.135 |
115 | 115 | 0.341 |
116 | 116 | 0.756 |
117 | 117 | 0.506 |
118 | 118 | 0.592 |
119 | 119 | 0.107 |
12 | 12 | 0.405 |
120 | 120 | 0.00942 |
121 | 121 | 0.587 |
122 | 122 | 0.971 |
123 | 123 | 0.64 |
124 | 124 | 0.131 |
125 | 125 | 0.334 |
126 | 126 | 0.47 |
127 | 127 | 0.168 |
128 | 128 | 0.0839 |
129 | 129 | 0.0621 |
13 | 13 | 0.672 |
130 | 130 | 0.247 |
131 | 131 | 0.715 |
132 | 132 | 0.168 |
133 | 133 | 0.0548 |
134 | 134 | 0.112 |
135 | 135 | 0.559 |
136 | 136 | 0.64 |
137 | 137 | 0.265 |
138 | 138 | 0.818 |
139 | 139 | 0.951 |
14 | 14 | 0.828 |
140 | 140 | 0.419 |
141 | 141 | 0.714 |
142 | 142 | 0.638 |
143 | 143 | 0.978 |
144 | 144 | 0.646 |
145 | 145 | 0.0972 |
146 | 146 | 0.122 |
147 | 147 | 0.265 |
148 | 148 | 0.139 |
149 | 149 | 0.555 |
15 | 15 | 0.6 |
150 | 150 | 0.129 |
151 | 151 | 0.276 |
152 | 152 | 0.0126 |
153 | 153 | 0.818 |
154 | 154 | 0.646 |
155 | 155 | 0.613 |
156 | 156 | 0.589 |
157 | 157 | 0.721 |
158 | 158 | 0.663 |
159 | 159 | 0.894 |
16 | 16 | 0.179 |
160 | 160 | 0.702 |
161 | 161 | 0.976 |
162 | 162 | 0.894 |
163 | 163 | 0.717 |
164 | 164 | 0.764 |
165 | 165 | 0.662 |
166 | 166 | 0.688 |
167 | 167 | 0.223 |
168 | 168 | 0.146 |
169 | 169 | 0.0976 |
17 | 17 | 0.0636 |
18 | 18 | 0.31 |
19 | 19 | 0.881 |
2 | 2 | 0.223 |
20 | 20 | 0.792 |
21 | 21 | 0.552 |
22 | 22 | 0.545 |
23 | 23 | 0.0131 |
24 | 24 | 0.0809 |
25 | 25 | 0.68 |
26 | 26 | 0.545 |
27 | 27 | 0.529 |
28 | 28 | 0.389 |
29 | 29 | 0.456 |
3 | 3 | 0.252 |
30 | 30 | 0.154 |
31 | 31 | 0.476 |
32 | 32 | 0.239 |
33 | 33 | 0.399 |
34 | 34 | 0.901 |
35 | 35 | 0.175 |
36 | 36 | 0.854 |
37 | 37 | 0.495 |
38 | 38 | 0.218 |
39 | 39 | 0.264 |
4 | 4 | 0.74 |
40 | 40 | 0.124 |
41 | 41 | 0.871 |
42 | 42 | 0.46 |
43 | 43 | 0.37 |
44 | 44 | 0.26 |
45 | 45 | 0.0948 |
46 | 46 | 0.511 |
47 | 47 | 0.594 |
48 | 48 | 0.26 |
49 | 49 | 0.587 |
5 | 5 | 0.641 |
50 | 50 | 0.332 |
51 | 51 | 0.429 |
52 | 52 | 0.184 |
53 | 53 | 0.657 |
54 | 54 | 0.419 |
55 | 55 | 0.321 |
56 | 56 | 0.219 |
57 | 57 | 0.521 |
58 | 58 | 0.823 |
59 | 59 | 0.249 |
6 | 6 | 0.229 |
60 | 60 | 0.255 |
61 | 61 | 0.953 |
62 | 62 | 0.981 |
63 | 63 | 0.124 |
64 | 64 | 0.937 |
65 | 65 | 0.212 |
66 | 66 | 0.504 |
67 | 67 | 0.513 |
68 | 68 | 0.265 |
69 | 69 | 0.26 |
7 | 7 | 0.71 |
70 | 70 | 0.00937 |
71 | 71 | 0.582 |
72 | 72 | 0.896 |
73 | 73 | 0.0202 |
74 | 74 | 0.171 |
75 | 75 | 0.181 |
76 | 76 | 0.671 |
77 | 77 | 0.046 |
78 | 78 | 0.0291 |
79 | 79 | 0.874 |
8 | 8 | 0.543 |
80 | 80 | 0.781 |
81 | 81 | 0.91 |
82 | 82 | 0.604 |
83 | 83 | 0.657 |
84 | 84 | 0.562 |
85 | 85 | 0.33 |
86 | 86 | 0.475 |
87 | 87 | 0.73 |
88 | 88 | 0.578 |
89 | 89 | 0.0306 |
9 | 9 | 0.846 |
90 | 90 | 0.683 |
91 | 91 | 0.472 |
92 | 92 | 0.228 |
93 | 93 | 0.958 |
94 | 94 | 0.522 |
95 | 95 | 0.336 |
96 | 96 | 0.956 |
97 | 97 | 0.921 |
98 | 98 | 0.826 |
99 | 99 | 0.286 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs10843
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000191 human urothelial cell sample
FF:0000210 human sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000548 (animal cell)
0000066 (epithelial cell)
0002371 (somatic cell)
0000255 (eukaryotic cell)
0000244 (transitional epithelial cell)
0000731 (urothelial cell)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0000483 (epithelium)
0005910 (transitional epithelium)
0000479 (tissue)
0006554 (urinary system structure)
0004119 (endoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0002050 (embryonic structure)
0005911 (endo-epithelium)
0005423 (developing anatomical structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0000119 (cell layer)
0005291 (embryonic tissue)
0000486 (multilaminar epithelium)
0000925 (endoderm)
0006598 (presumptive structure)
0000365 (urothelium)
0002532 (epiblast (generic))
0001008 (renal system)
0006595 (presumptive endoderm)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA